These two effects were not observed during B2R agonist treatment at the same dosage and by the same route in mice non-submitted to cerebral ischemia or in other experimental settings, including in diabetes, ruling out renal toxicity of the B2R agonist12, 35 (unreported data). This evidence concerns the gene BDKRB2 and Cerebral ischemia.